Skip to main content
. 2015 Sep 9;78(5):520–526. doi: 10.1038/pr.2015.145

Figure 1.

Figure 1

Long-term effect of MSC treatment on sensorimotor behavior over time. Mice received either 0.5 × 106 MSCs or vehicle intranasally at 10 d post-HI. Performance in the CRT was assessed at 10 d (i.e., before treatment) and 28 d and at 6 and 9 mo post-HI induction or sham operation. The results show that MSC administration improves performance in the CRT up to 9 mo post-HI. P < 0.001; P < 0.001 (HI-MSC 28 d vs. HI-MSC 9 mo) with two-way ANOVA and Bonferroni post-hoc test. Animal numbers: 10-d sham, n = 16; HI-vehicle, n = 17; HI-MSC, n = 17; 28-d sham, n = 15; HI-vehicle, n = 17; HI-MSC, n = 17; 6-mo sham, n = 15; HI-vehicle, n = 17; HI-MSC, n = 14; 9-mo sham, n = 13; HI-vehicle, n = 16; HI-MSC, n = 13. HI, hypoxia–ischemia; MSC, mesenchymal stem cell.